CLINICAL PICTURES
The clinical pictures we treat in our clinical trials are preferably:
ASTHMA
Asthma is a chronic disease of the airways that leads to breathing difficulties. In asthma, the airways are inflamed and sensitive, which can lead to symptoms such as coughing, wheezing, shortness of breath, and tightness in the chest. These symptoms can be triggered by various triggers such as allergens, air pollution, physical exertion, or cold air. Asthma can usually be treated with medications that reduce inflammation and widen the airways.
COPD
COPD, or chronic obstructive pulmonary disease, is a progressive disease of the lungs characterized by a permanent narrowing of the airways. It mainly includes two diseases: chronic bronchitis and emphysema. The most common symptoms
include shortness of breath, coughing, and expectoration. COPD is often caused by prolonged smoking or exposure to harmful air pollutants. The disease cannot be cured, but it can be treated with medication to relieve symptoms, reduce the underlying inflammation, and improve quality of life.
COPD
COPD, or chronic obstructive pulmonary disease, is a progressive disease of the lungs characterized by a permanent narrowing of the airways. It mainly includes two diseases: chronic bronchitis and emphysema. The most common symptoms
include shortness of breath, coughing, and expectoration. COPD is often caused by prolonged smoking or exposure to harmful air pollutants. The disease cannot be cured, but it can be treated with medication to relieve symptoms, reduce the underlying inflammation, and improve quality of life.
ALLERGIC RHINITIS
Allergic rhinitis, also known as hay fever, is an allergic reaction that affects the nasal mucosa. It occurs when the immune system overreacts to certain allergy triggers (allergens) such as pollen, house dust mites, animal hair, or mold. The most common symptoms include sneezing, itchy and runny nose, and itchy eyes. These symptoms can occur seasonally (e.g., during pollen season) or year-round, depending on the triggers. Treatment includes antihistamines, nasal sprays, newer therapeutic approaches, and measures to avoid allergens.
PULMONARY FIBROSIS
Pulmonary fibrosis is a disease in which the lung tissue becomes scarred and stiff, making breathing difficult. This scarring can be caused by various factors, including prolonged exposure to pollutants, certain medications, autoimmune diseases, or can also be idiopathic, meaning that the cause is unknown. The most common symptoms include shortness of breath, dry cough, and fatigue. Pulmonary fibrosis is a chronic disease that is not curable, but treatment can help relieve symptoms and slow the progression of the disease.
PULMONARY FIBROSIS
Pulmonary fibrosis is a disease in which the lung tissue becomes scarred and stiff, making breathing difficult. This scarring can be caused by various factors, including prolonged exposure to pollutants, certain medications, autoimmune diseases, or can also be idiopathic, meaning that the cause is unknown. The most common symptoms include shortness of breath, dry cough, and fatigue. Pulmonary fibrosis is a chronic disease that is not curable, but treatment can help relieve symptoms and slow the progression of the disease.
BRONCHIECTASIS
Bronchiectasis is a chronic disease in which the bronchi, the airways in the lungs, are permanently dilated and damaged. This dilation leads to an accumulation of mucus, which increases the risk of infection and impairs respiratory function. The most common symptoms include persistent cough, expectoration of mucus, shortness of breath, and frequent respiratory infections. Bronchiectasis can be caused by various factors, including chronic lung diseases, infections, or genetic diseases such as cystic fibrosis. Treatment aims to relieve symptoms, prevent infections, and improve respiratory function.
CYSTIC FIBROSIS
Cystic fibrosis, also known as cystic fibrosis, is a genetic disease that mainly affects the lungs and digestive system. It is caused by a mutation in the CFTR gene, which leads to the production of thick, sticky mucus. This mucus can clog the airways and lead to repeated infections, shortness of breath, and lung damage. It can also impair the function of the pancreas, making it difficult to digest nutrients. The most common symptoms include chronic cough, breathing problems, frequent lung infections, and digestive disorders. Cystic fibrosis is a chronic disease that is currently not curable, but treatment can help manage symptoms and improve quality of life.
CYSTIC FIBROSIS
Cystic fibrosis, also known as cystic fibrosis, is a genetic disease that mainly affects the lungs and digestive system. It is caused by a mutation in the CFTR gene, which leads to the production of thick, sticky mucus. This mucus can clog the airways and lead to repeated infections, shortness of breath, and lung damage. It can also impair the function of the pancreas, making it difficult to digest nutrients. The most common symptoms include chronic cough, breathing problems, frequent lung infections, and digestive disorders. Cystic fibrosis is a chronic disease that is currently not curable, but treatment can help manage symptoms and improve quality of life.
NEURODERMATITIS
Neurodermatitis, also known as atopic dermatitis, is a chronic skin disease characterized by dry, itchy, and inflamed skin. It often occurs in children but can also affect adults. The exact causes are not fully understood, but genetic factors, allergies, and environmental factors play a role. Symptoms include intense itching, redness, scaling, and skin rashes that can occur in episodes. Treatment includes the use of moisturizing creams, corticosteroids to relieve inflammation, and, if necessary, antihistamines to combat itching. For some years now, newer therapies have also been available that positively influence the underlying inflammation.
Healthy subjects
In early phases of clinical trials, healthy subjects are often selected to investigate the effects of the drug on a healthy organism. Healthy subjects are important because the effects of a drug can be considered in isolation, without existing health problems influencing the results. These studies are crucial to ensure that the drug can be safely tested in later phases of the clinical trial.
Healthy subjects
In early phases of clinical trials, healthy subjects are often selected to investigate the effects of the drug on a healthy organism. Healthy subjects are important because the effects of a drug can be considered in isolation, without existing health problems influencing the results. These studies are crucial to ensure that the drug can be safely tested in later phases of the clinical trial.
NASAL POLYPS
Nasal polyps are soft, painless growths of the nasal mucosa that can occur in the nose or paranasal sinuses. They often arise as a result of chronic inflammation, allergies, or asthma. Symptoms include a blocked nose, reduced sense of smell, nasal discharge, and frequent sinus infections. Nasal polyps can impair breathing and greatly affect well-being. Treatment often includes medications such as corticosteroids and so-called biologics to reduce inflammation, and in severe cases, surgical removal may be necessary.
COVID-19
COVID-19 is a disease caused by the coronavirus SARS-CoV-2, which was first identified in Wuhan, China, in late 2019. The disease can range from mild symptoms such as cough, fever, and shortness of breath to severe illness and even death lead. COVID-19 is mainly transmitted by droplet infection when an infected person coughs, sneezes, or speaks. The therapy of COVID-19 depends on the severity of the disease and includes various approaches. In more severe cases, antiviral drugs and antibodies can be used to inhibit virus replication.
COVID-19
COVID-19 is a disease caused by the coronavirus SARS-CoV-2, which was first identified in Wuhan, China, in late 2019. The disease can range from mild symptoms such as cough, fever, and shortness of breath to severe illness and even death lead. COVID-19 is mainly transmitted by droplet infection when an infected person coughs, sneezes, or speaks. The therapy of COVID-19 depends on the severity of the disease and includes various approaches. In more severe cases, antiviral drugs and antibodies can be used to inhibit virus replication.
VACCINATIONS
Vaccinations work by stimulating the immune system to develop an immune response against specific pathogens without the person actually contracting the disease. Vaccines contain weakened or inactivated pathogens, parts of the pathogen (such as proteins), or genetic material (such as mRNA). These components are recognized as antigens. The immune system responds to the antigens by activating specific immune cells. If the vaccinated person is later exposed to the real pathogen, the immune system can react immediately and fight off the infection, reducing the likelihood of disease.
